0000905718-20-000969.txt : 20200917 0000905718-20-000969.hdr.sgml : 20200917 20200917210719 ACCESSION NUMBER: 0000905718-20-000969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200915 FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zarrabian Saiid CENTRAL INDEX KEY: 0001495521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 201182564 MAIL ADDRESS: STREET 1: P.O. BOX 675765 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kintara Therapeutics, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130123 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 kintara_fm4sep152020.xml X0306 4 2020-09-15 0 0001498382 Kintara Therapeutics, Inc. KTRA 0001495521 Zarrabian Saiid 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 1 1 0 0 President and CEO Options (Right to Buy) 1.70 2020-09-15 4 A 0 2715004 0 A 2030-09-15 Common Stock 2715004 2715004 D The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 1/6th of the options vest on March 15, 2021, with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 15, 2021. /s/ Anthony Scott Praill, attorney-in-fact for Saiid Zarrabian 2020-09-17